Search Results - "Virone, A"
-
1
Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-04-2016)“…Objective To define parameters predictive of lymphoma development in patients with primary Sjögren's syndrome (SS). Methods A multicenter case–control survey…”
Get full text
Journal Article -
2
The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells
Published in Leukemia (01-02-2016)“…The phosphoinositide 3-kinases (PI3Ks) are critical components of the B-cell receptor (BCR) pathway and have an important role in the pathobiology of chronic…”
Get full text
Journal Article -
3
-
4
Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study
Published in Annals of the rheumatic diseases (01-10-2016)“…To study the responsiveness of a combined power Doppler and greyscale ultrasound (PDUS) score for assessing synovitis in biologic-naïve patients with…”
Get more information
Journal Article -
5
Stable cell line of T-SV40 immortalized human glomerular visceral epithelial cells
Published in Kidney international (01-11-1991)“…Stable cell line of T-SV40 immortalized human glomerular visceral epithelial cells. Human subcultures (third passage) of glomerular visceral epithelial cells…”
Get full text
Journal Article Conference Proceeding -
6
In vitro and in vivo effects of UP 269‐6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation
Published in British journal of pharmacology (01-02-1997)“…1 The present studies were designed to measure the affinity of UP 269‐6, a newly developed angiotensin AT1 receptor antagonist, for vascular AT1 receptors from…”
Get full text
Journal Article -
7
In vitro pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist
Published in Fundamental & clinical pharmacology (01-01-1995)“…f1p4in vitro pharmacology of UP 269-6, a novel nonpeptide angiotensin II antagonist, was examined in radioligand binding and functional isolated tissue assays…”
Get more information
Journal Article -
8
149 Characterization of novel series of selective PI3Kalpha and PI3Kalpha/mTOR-dual inhibitors
Published in European journal of cancer supplements (2010)Get full text
Journal Article -
9
115 Discovery and characterization of PI3Kbeta isoform-selective inhibitors
Published in European journal of cancer supplements (2010)Get full text
Journal Article -
10
-
11
Abcès musculaires aseptiques associés à un syndrome myélodysplasique
Published in La revue de medecine interne (01-06-2013)Get full text
Journal Article -
12
Erratum: The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells
Published in Leukemia (01-09-2016)“…Correction to: Leukemia (2016) 30, 337–345; doi:10.1038/leu.2015.241; Published 10 November 2015 Following the publication of this article, the authors noted…”
Get full text
Journal Article -
13
The pan phosphoinositide 3-kinase mammalian target of rapamycin inhibitor SAR245409
Published in Leukemia (01-09-2016)Get full text
Journal Article -
14
Synthesis and angiotensin II receptor antagonist activity of C-linked pyrimidine derivatives
Published in European journal of medicinal chemistry (1995)“…The synthesis and pharmacological activity of nonpeptide angiotensin II (Ang II) receptor antagonists are presented. These 3- N-substituted pyrimidine-4(3…”
Get full text
Journal Article -
15
A structure-based approach to selective PI3Kbeta inihibition
Published in Acta crystallographica. Section A, Foundations of crystallography (07-08-2012)“…Abstract only…”
Get full text
Journal Article -
16
Synthesis and structure-activity relationships of novel benzimidazole and imidazo[4,5-b]pyridine acid derivatives as thromboxane A2 receptor antagonists
Published in Journal of medicinal chemistry (01-04-1993)“…A series of 1-benzylbenzimidazole and 3-benzylimidazo[4,5-b]pyridine substituted in the 2-position by an alkanoic or mercaptoalkanoic acid chain was…”
Get full text
Journal Article -
17
Intracellular expression of an antibody fragment-neutralizing p21 Ras promotes tumor regression
Published in Cancer research (Chicago, Ill.) (15-03-1998)“…Mutated ras genes are found in a large number of human tumors and, therefore, constitute one of the primary targets for cancer treatment. Microinjection of the…”
Get full text
Journal Article -
18
Metastatic phenotype of murine tumor cells expressing different cooperating oncogenes
Published in International journal of cancer (09-07-1992)“…Four murine cellular tumor models expressing various combinations of oncogenes (SV40 large T and v-Ha-ras, SV40 large T and v-src, SV40 large T and neu,…”
Get more information
Journal Article -
19
Transfert du gène p53 sauvage dans une lignée humaine de carcinome épidermoïde
Published in Cancer radiothérapie (01-09-1998)Get full text
Journal Article -
20
Cancer gene therapy mediated by CTS1, a p53 derivative: advantage over wild-type p53 in growth inhibition of human tumors overexpressing MDM2
Published in Cancer gene therapy (01-05-2000)“…Recently, a new p53 derivative has been designed, namely chimeric tumor suppressor 1 (CTS1), in which the p53 domains that are known to mediate p53…”
Get full text
Journal Article